https://openicon.com/confsums/sgen_main.html
Seagen analysis, news, and conference notes
Seagen (SGEN) analyst coverage
news andseagenanalysisconferencenotes
https://www.benzinga.com/analyst-ratings/22/04/26912236/expert-ratings-for-seagen
Expert Ratings for Seagen - Benzinga
Apr 29, 2022 - Within the last quarter, Seagen (NASDAQ:SGEN) has observed the following analyst ratings:
expertratingsseagenbenzinga
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/pfizer-completes-purchase-of-cancer-focused-seagen/106015141
Pfizer completes purchase of cancer-focused Seagen, ETHealthworld
Pfizer said Thursday it completed a $43 billion takeover of cancer-focused biotech company Seagen that the pharma giant said would enable it to double its...
pfizercompletespurchasecancerfocused
https://daiichisankyo.us/en/press-releases/-/article/arbitrator-rules-in-favor-of-daiichi-sankyo-in-dispute-with-seagen
Arbitrator Rules in Favor of Daiichi Sankyo in Dispute with Seagen- Daiichi Sankyo US
Read and download our press releases.
daiichi sankyoarbitratorrulesfavor
https://www.seagen.io/
SeaGen - Blue Tech For a Blue Planet
Blue tech for a blue planet.
for aseagenbluetechplanet
https://www.mypharma-editions.com/tags/seagen
Seagen | MyPharma Editions
seagenmypharmaeditions
https://www.openicon.com/confsums/2022/sgen_07_28_2022.html
Seagen revenue up 28% y/y; SGEN analyst conference call for Q2 2022
Seagen Q2 2022 results summary
https://daiichisankyo.us/press-releases/-/article/daiichi-sankyo-provides-update-on-patent-dispute-with-seagen
Daiichi Sankyo Provides Update on Patent Dispute with Seagen- Daiichi Sankyo US
Read and download our press releases.
daiichi sankyopatent disputeprovidesupdateseagen
https://www.merakifsi.com/post/buffett-blast-pfizer-eyes-seagen-bund-hits-12-year-high-what-s-moving-markets
Buffett blast, Pfizer eyes Seagen, Bund hits 12-year high - what's moving markets
Feb 27, 2023 - Warren Buffett blasts the new buyback tax as Berkshire Hathaway's performance sags under pressure from last year's market volatility. Pfizer is reportedly in...
https://litigation.rpxcorp.com/litigation/txedce-201426-seagen-v-daiichi-sankyo
2:20-cv-00337 | Seagen Inc. v. Daiichi Sankyo Co., Ltd. | RPX Empower
Parties, patents and docket of Seagen Inc. v. Astrazeneca Uk Ltd. and 2 other defendants (2:20-cv-00337) from Eastern District of Texas filed on 10/19/2020 and...
https://public.seagen.io/deployments/plymouth-aquarium-shark-tank
SeaGen
seagen